FERNANDO SILVA: Open Payments
NPI 1558777425 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,130 in 163 payments from 45 companies in 2025. Trend: 2023 $3,508 · 2024 $4,421 · 2025 $4,130
Food & beverage: $3,776Education: $354
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $332 |
| Gilead Sciences, Inc. | 9 | $313 |
| Merck Sharp & Dohme LLC | 11 | $294 |
| Novartis Pharmaceuticals Corporation | 11 | $214 |
| Ipsen Biopharmaceuticals, Inc | 3 | $212 |
| GlaxoSmithKline, LLC. | 12 | $195 |
| AstraZeneca Pharmaceuticals LP | 9 | $183 |
| PFIZER INC. | 8 | $170 |
| Celgene Corporation | 6 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $161 |
Products named: KEYTRUDA, Trodelvy, REBLOZYL, Venclexta, OPDIVO, ENHERTU, OJJAARA, Vonjo.
Industry payments across FL — which companies pay providers there.
